LATEST ALERTS

District of Columbia - United States Medical cannabis bill increasing access becomes law…
United States - Washington Interstate cannabis trade bill passes Senate and heads to House…
South Dakota - United States Governor vetoes industrial hemp revision bill…
South Dakota - United States Medical cannabis use prohibited if pregnant or breastfeeding…
South Dakota - United States Governor signs bill on medical cannabis qualifying conditions…
Oklahoma - United States Medical cannabis-related bill passes Senate…
Kentucky - United States Delta-8 THC bill signed by governor and becomes law…
Europe EC reveals environmental claims proposal…
Spain Parties rally behind Podemos proposal for hemp regulation…
Maryland - United States Personal use cannabis good, ‘volume dealing’ bad, House says…
North Dakota - United States Legislature approves easier cannabis rules for over-65s in hospices…
New Hampshire - United States House backs home growing for medical cannabis patients…

View all

News analysis

FDA cracks down again on health claims, but seems receptive to CBD

Written by Barnaby Page || 26th November 2019 || News analysis | Health and science | Marketing and retailing | Policy and Politics | Geographies: United States

Scrutiny of the CBD market appears to be growing at the US Food and Drug Administration (FDA), which this week reprimanded a further 15 companies for selling CBD products as drugs and also updated its advice to consumers on potential dangers ...

Are you already a subscriber? login here

Enjoy free subscription access

Get access to premium content that is normally only available for subscribers.
For the duration of a week, you can read our news analysis, identify market trends and understand upcoming changes in the industry, which will enable you to get ahead of your competitors.

I WANT A FREE TRIAL NOW